A highly sensitive and quantitative telomerase activity assay with pancreatic juice is useful for diagnosis of pancreatic carcinoma without problems due to polymerase chain reaction inhibitors: Analysis of 100 samples of pancreatice juice from consecutive patients

Cancer

Volumn 101, Issue 10, 2004, Pages 2309-2317

  Ohuchida, Kenoki ^a   Mizumoto, Kazuhiro ^a   Ishikawa, Nami ^a   Sato, Norihiro ^a   Nagai, Eishi ^a   Yamaguchi, Koji ^a   Takaishi, Hideki ^b   Ide, Toshinori ^b   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Hybridization protection assay; Pancreatic carcinoma; Pancreatic juice; Polymerase chain reaction inhibitor; Telomerase

Indexed keywords

PROTEINASE; RIBONUCLEASE; TELOMERASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CYTODIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME ACTIVITY; ENZYME ASSAY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS JUICE; PANCREATITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TELOMERIC REPEAT AMPLIFICATION PROTOCOL;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL ASSAY; CARCINOMA, PANCREATIC DUCTAL; ENZYME INHIBITORS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; PANCREATIC JUICE; PANCREATIC NEOPLASMS; PANCREATITIS; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 7644226411     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20649     Document Type: Article

References (24)

1. Warshaw AL, Fernandez-del Castillo C. Pancreatic carcinoma. N Engl J Med. 1992;326:455-465.
2. Niederhuber JE, Brennan MF, Menck HR. The National Cancer Data Base report on pancreatic cancer. Cancer. 1995;76: 1671-1677.
3. Bramhall SR, Allum WH, Jones AG, Allwood A, Cummins C, Neoptolemos JP. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995; 82:111-115.
4. Gilinsky NH, Bornman PC, Girdwood AH, Marks IN. Diagnostic yield of endoscopic retrograde cholangiopancreatography in carcinoma of the pancreas. Br J Surg. 1986;73:539-543.
5. Pasanen P, Partanen K, Pikkarainen P, Alhava E, Pirinen A, Janatuinen E. Diagnostic accuracy of ultrasound, computed tomography and endoscopic retrograde cholangiopancreatography in the detection of pancreatic cancer in patients with jaundice or cholestasis. In Vivo. 1992;6:297-301.
6. Nakaizumi A, Tatsuta M, Uehara H, et al. Cytologic examination of pure pancreatic juice in the diagnosis of pancreatic carcinoma. The endoscopic retrograde intraductal catheter aspiration cytologic technique. Cancer. 1992;70:2610-2614.
7. Mitchell ML, Carney CN. Cytologic criteria for the diagnosis of pancreatic carcinoma. Am J Clin Pathol. 1985;83:171-176.
8. Harley CB, Kim NW, Prowse KR, et al. Telomerase, cell immortality, and cancer. Cold Spring Harb Symp Quant Biol. 1994;59:307-315.
9. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science. 1994;266:2011-2015.
10. Tahara H, Nakanishi T, Kitamoto M, et al. Telomerase activity in human liver tissues: comparison between chronic liver disease and hepatocellular carcinomas. Cancer Res. 1995;55:2734-2736.
11. Hiyama K, Hiyama E, Ishioka S, et al. Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 1995;87:895-902.
12. Wright WE, Piatyszek MA, Rainey WE, Byrd W, Shay JW. Telomerase activity in human germline and embryonic tissues and cells. Dev Genet. 1996;18:173-179.
13. Suehara N, Mizumoto K, Muta T, et al. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states. Clin Cancer Res. 1997;3:993-998.
14. Suehara N, Mizumoto K, Tanaka M, et al. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis. Clin Cancer Res. 1997;3(12 Pt. 1):2479-2483.
15. Uehara H, Nakaizumi A, Tatsuta M, et al. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations. Am J Gastroenterol. 1999;4:2513-2518.
16. Myung SJ, Kim MH, Kim YS, et al. Telomerase activity in pure pancreatic juice for the diagnosis of pancreatic cancer may be complementary to K-ras mutation. Gastrointest Endosc. 2000;51:708-713.
17. Hirose M, Abe-Hashimoto J, Ogura K, Tahara H, Ide T, Yoshimura T. A rapid, useful and quantitative method to measure telomerase activity by hybridization protection assay connected with a telomeric repeat amplification protocol. J Cancer Res Clin Oncol. 1997;123:337-344.
18. Nakamura Y, Tahara E, Tahara H, Yasui W, Ide T. Quantitative reevaluation of telomerase activity in cancerous and noncancerous gastrointestinal tissues. Mol Carcinog. 1999; 26:312-320.
19. Takaishi H, Kitamoto M, Takahashi S, et al. Precancerous hepatic nodules had significant levels of telomerase activity determined by sensitive quantitation using a hybridization protection assay. Cancer. 2000;88:312-317.
20. Ikeda S, Matsumoto S, Yoshimoto H, Tanaka M, Yamaguchi K. Endoscopic balloon catheter pancreatography using catheter retaining technique (in Japanese with an English abstract). Stomach Intestine. 1984;19:1231-1242
21. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
22. Pan C, Xue BH, Ellis TM, Peace DJ, Diaz MO. Changes in telomerase activity and telomere length during human T lymphocyte senescence. Exp Cell Res. 1997;231:346-353.
23. Suehara N, Mizumoto K, Kusumoto M, et al. Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer. Am J Gastroenterol. 1998;93:1967-1971.
24. Inoue H, Tsuchida A, Kawasaki Y, Fujimoto Y, Yamasaki S, Kajiyama G. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity. Cancer. 2001;91:35-41.